RUNX1 Research Program

The National Institutes of Health is conducting a groundbreaking study of RUNX1-FPD patients to better understand the clinical features of this rare condition. The study aims to uncover how different types of #RUNX1 mutations affect patients and why some progress to blood cancer while others do not. This research is a vital step toward advancing our understanding of RUNX1-FPD in order to find effective treatments. Learn more about this essential work: https://bit.ly/3AV2DhF  #BloodCancerResearch #NIH #RareDisease

🌟𝗜𝗺𝗽𝗼𝗿𝘁𝗮𝗻𝘁 𝗢𝗽𝗽𝗼𝗿𝘁𝘂𝗻𝗶𝘁𝘆 𝗳𝗼𝗿 𝗥𝗨𝗡𝗫𝟭-𝗙𝗣𝗗 𝗣𝗮𝘁𝗶𝗲𝗻𝘁𝘀! 🌟 MD Anderson Cancer Center is running a clinical trial to assess the safety and feasibility of collecting and banking blood stem cells from RUNX1-FPD patients. With advances in gene editing, there’s hope to one day correct RUNX1 variants in stored cells, potentially improving health using a patient’s own cells. 🔗 Learn more: https://lnkd.in/gi82vB48 #RUNX1FPD #BloodStemCells #GeneEditing #ClinicalTrials

RRP and Alex's Lemonade Stand Foundation are excited to announce that we are now accepting applications for the RRP-ALSF 2025 Early Career Investigator (ECI) Grant Program! This grant offers up to $180,000 over three years and is designed to support early-career scientists focused on developing therapies that prevent the progression of pre-leukemia to leukemia in patients with #RUNX1FPD. Researchers interested in making an impact on inherited hematologic malignancy predisposition disorders are encouraged to apply. Proposals that prioritize translating research from bench to bedside will receive special consideration. Application Deadline: December 19th, 2024, by 8:00 PM EST Learn more and apply here: https://lnkd.in/gGDXnfYg

We are thrilled to share that the RUNX1 Research Program and the American Cancer Society have joined forces to launch the LEAP (Leukemia Exploration And Prevention) grant program. With over $2.8 million in funding, this initiative is dedicated to advancing research in the interception and prevention of blood cancers, particularly for those affected by #RUNX1FPD. If your work is driving innovation in blood cancer prevention, we invite you to apply. The application deadline is Oct 29. Discover more and apply here: https://bit.ly/liLEAPGrant #CancerResearch #LeukemiaPrevention #RUNX1FPD #GrantOpportunity

Coming Up in 𝗧𝗪𝗢 𝗪𝗘𝗘𝗞𝗦! Mark your calendars for Monday, September 23 at 1:00 PM ET for our second #Spanish HHM Webinar. Dr. Ximena Jordan from the University of Pennsylvania will present, followed by a Q&A with Drs. Sofia Grille, María Díez Campelo, and María Roberta Demichelis Gómez. This is a unique opportunity to connect with experts in hematology and cancer research. Register now: https://lnkd.in/gkKHr-jq #CancerResearch #Hematology #MedicalEducation

𝗥𝗥𝗣'𝘀 𝗔𝘂𝗴𝘂𝘀𝘁 𝗡𝗲𝘄𝘀𝗹𝗲𝘁𝘁𝗲𝗿 𝗶𝘀 𝗵𝗲𝗿𝗲! This edition is packed with exciting info about the $2.8M LEAP Grant Program from RRP & @AmericanCancer—applications are open until Oct 29! Plus register to learn about the Stem Cell Harvesting & Banking clinical trial at @MDAnderson, and our next HHM webinar presented in Spanish. Read more:  https://lnkd.in/guA-wKT5

We're excited to announce a new partnership between RRP and the American Cancer Society: the Leukemia Exploration And Prevention (LEAP) grant program. This initiative offers over $2.8 million in funding to support pioneering research focused on the interception and prevention of blood cancers, specifically for individuals with #RUNX1FPD. If your research is aimed at making strides in blood cancer prevention, we encourage you to apply. The deadline for applications is Oct 29. Learn more and submit your application here: https://bit.ly/liLEAPGrant #CancerResearch #LeukemiaPrevention #RUNX1FPD #GrantOpportunity

Save the Date! Our second #Spanish HHM Webinar on Monday, September 23 at 1:00 PM ET. Dr. Ximena Jordan from the University of Pennsylvania will lead the session, followed by a Q&A with Drs. Sofía Grille, MD, PhD, María Díez Campelo, and María Roberta Demichelis Gómez. Don't miss this chance to engage with top experts and deepen your knowledge. Secure your spot today: https://lnkd.in/gkKHr-jq #CancerResearch #Hematology #MedicalEducation

September is Leukemia and Lymphoma Awareness Month—a time to honor the strength of everyone affected by blood cancers and to reflect on the remarkable progress in blood cancer research. These advancements underscore the dedication of the scientific and medical communities, but there is still work to be done. Let’s all reaffirm our commitment to supporting research, improving early detection, and developing innovative therapies that can transform lives. Whether you're in the lab, clinic, or simply care about this cause, your involvement makes a difference. Please consider supporting these efforts with a donation of any size today: https://lnkd.in/gJUU37X6

🩸 𝗦𝗲𝗽𝘁𝗲𝗺𝗯𝗲𝗿 𝗶𝘀 𝗕𝗹𝗼𝗼𝗱 𝗖𝗮𝗻𝗰𝗲𝗿 𝗔𝘄𝗮𝗿𝗲𝗻𝗲𝘀𝘀 𝗠𝗼𝗻𝘁𝗵 🩸 As we observe Blood Cancer Awareness Month, it's crucial to highlight the importance of research in understanding and combating blood cancers, including those with a genetic predisposition like #RUNX1FPD. This disease not only increases the risk of developing blood cancers, but also presents unique challenges in prevention and treatment strategies. This month, let’s amplify our commitment to advancing research, fostering collaborations, and exploring innovative therapies that could lead to more effective interventions. By deepening our understanding of genetic predispositions, we can move closer to precision medicine and ultimately, a cure. Together, we can make a significant impact in the fight against blood cancer. #BloodCancerAwarenessMonth #RUNX1FPD #Hematology #CancerResearch #Genomics #PrecisionMedicine